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Abstract
 
Transition of immature antigen presenting cells (APCs) to the state of professional APCs is es-
sential for initiation of cell-mediated immune responses to pathogens. Signal transduction via
molecules of the Toll-like receptor (TLR)/interleukin 1 receptor (IL-1R) pathway is critical
for activation of APCs either by pathogen-derived pattern ligands like lipopolysaccharides
(LPS) or by CD40 ligation through T helper cells. The capacity of bacterial DNA (CpG-DNA)
to induce APCs to differentiate into professional APCs represents an interesting discovery.
However, the signaling pathways involved are poorly understood. Here we show that CpG-
DNA activates the TLR/IL-1R signaling pathway via the molecules myeloid differentiation
marker 88 (MyD88) and tumor necrosis factor receptor–associated factor 6 (TRAF6), leading
 
to activation of kinases of the I
 
k
 
B kinase complex and the c-jun NH
 
2
 
-terminal kinases. More-
over, cells of TLR2- and TLR4-deficient mice are activated by CpG-DNA, whereas cells of
MyD88-deficient mice do not respond. The data suggest that CpG-DNA initiates signaling via
the TLR/IL-1R pathway in APCs in a manner similar to LPS and to T helper cell–mediated
CD40 ligation. Activation of the TLR/IL-1R signaling pathway by foreign bacterial DNA
may be one way to initiate innate defense mechanisms against infectious pathogens in vivo.
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Introduction
 
Key features of the innate immune system include the abil-
ity to limit an infectious challenge as the first line of host
defense and to control the initiation of adaptive immune
responses via antigen presentation in the context of costim-
ulatory molecules and cytokines. Cells of the innate im-
mune system such as macrophages and dendritic cells dis-
criminate between “self” and infectious “non-self” via
constitutive receptors that identify pattern ligands synthe-
sized exclusively by pathogens, so-called pattern recogni-
 
tion factors (PRFs). Defined examples are LPS, bacterial
lipoproteins (BLPs) and bacterial DNA (CpG-DNA). Re-
cently it has been shown that immune cell activation by
LPS and BLP requires Toll-like receptors (TLRs; 1–3).
Through their cytoplasmic Toll/IL-1R homology domain
(TIR domain), TLR2 and TLR4, as well as members of
the IL-1R family, recruit the adapter molecule myeloid
differentiation marker 88 (MyD88) to initiate signal trans-
duction (4–6). In case of the IL-1R complex it has been
shown that MyD88 and the IL-1R–associated kinase
(IRAK)-1 are transiently recruited to the receptor com-
plex, followed by interaction of IRAK-1 (and possibly
other IRAKs such as IRAK-2 and IRAKm; references 7,
8) with TNF receptor–associated factor (TRAF)6 (6).
TRAF6 has also been found to interact directly with the
cytoplasmic tail of CD40 (9). This might explain the similar
downstream events of TLR- and CD40-dependent signal-
 
ing such as activation of kinases of the IKK I
 
k
 
B kinase
 
(IKK) complex and the stress kinases c-Jun NH
 
2
 
-terminal
kinase (JNK)1/2 and p38. That this pathway is essential in
LPS signaling and Th cell–mediated CD40 ligation is sup-
ported by the LPS “non responder” phenotype of MyD88-
 
deficient mice (10) and the defective LPS- and CD40-
dependent signaling in TRAF6-deficient mice (11).
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Recently, it has been shown that CpG-DNA, like LPS
and BLP, induces gene expression via classic, receptor-driven
signaling cascades such as the nuclear factor (NF)-
 
k
 
B and
stress kinase pathways and the extracellular signal–regulated
kinase pathway (12, 13). In spite of their structural diver-
sity, the immunobiology of LPS or BLP shows remarkable
similarity to that of CpG-DNA (14). Together, these ob-
servations led us to test whether CpG-DNA signals via the
TLR/IL-1R signaling pathway.
 
Materials and Methods
 
Cell Culture, Expression Plasmids, and Reagents.
 
The murine
macrophage cell line RAW264.7 was grown in LowTox Clicks/
RPMI (Biochrom) supplemented with 10% FCS (Seromed
 
®
 
;
Biochrom). Peritoneal macrophages were cultured in RPMI
1640 medium (GIBCO BRL) supplemented with 10% fetal bo-
vine serum (GIBCO BRL). To obtain peritoneal macrophages,
mice were intraperitoneally injected with 2 ml of 4% thioglycol-
late. 3 d later, peritoneal exudate cells were isolated by peritoneal
lavage with ice-cold Hanks’ buffered salt solution. Cells were cul-
tured for 2 h and washed extensively with Hanks’ buffered salt
solution to remove nonadherent cells. Adherent cells were used as
peritoneal macrophages for stimulation with CpG-DNA. In the
experiments where Poly I:C was used, cell culture medium was
supplemented with 10 
 
m
 
g/ml polymyxin B (Sigma-Aldrich) dur-
ing the time period of stimulation to exclude effects of trace
amounts of LPS in the Poly I:C preparation.
The expression vectors for human TRAF6-C (AS289-522;
reference 4) and TRAF6 wild-type were gifts from Tularik, Inc.
A 5
 
9
 
 Flag epitope–tagged COOH terminus of murine MyD88
(AS158-302) was amplified by reverse transcription PCR from
murine spleen RNA and cloned into a modified pcDNA3 vector
(Invitrogen), containing an untranslated intervening sequence
from the mouse IgG heavy chain for improved expression in eu-
karyotic cells (pCX).
Phosphothioate stabilized CpG-ODN (TCC-ATG-ACG-
TTC-CTG-ATG-CT) and GpC-ODN (TCC-ATG-AGC-TTC-
CTG-ATG-CT) (15) were purchased from TIB MOLBIOL, LPS
(
 
Salmonella minnesota
 
 Re 595) was purchased from Sigma-Aldrich,
and Poly I:C was from Amersham Pharmacia Biotech.
 
Mice.
 
Generation of the mutant mice (TLR2-, TLR4-, and
MyD88-deficient) has been described previously (2, 3, 16). Age-
matched groups of wild-type and TLR4- and MyD88-deficient
mice were used for the experiments.
 
ELISA.
 
Production of TNF from peritoneal macrophages
was measured by ELISA according to the instructions of the man-
ufacturer (Genzyme). Each value shown represents the mean of
two independent stimulations.
 
Luciferase Reporter Plasmid Transfection and Luciferase Assay.
 
To
investigate transcriptional activity of the IL-12 p40-promoter in
transient transfection assays, we used a plasmid containing the lu-
ciferase gene under control of the 
 
2
 
703 bp region of the murine
IL-12 p40 gene, a gift from K. Murphy (Harvard University, Bos-
ton, MA [17]). 5–10 
 
3
 
 10
 
6
 
 RAW264.7 cells were transfected by
electroporation in a 400 
 
m
 
l final volume (RPMI/25% FCS) at 280
V/960 
 
m
 
F in a Bio-Rad Laboratories gene pulser. 7 
 
m
 
g of re-
porter plasmid was used together with different amounts of spe-
cific expression vectors as indicated in the figure legends. The
overall amount of plasmid DNA was held constant at 20 
 
m
 
g per
electroporation by addition of the appropriate empty expression
vector. After electroporation, cells were washed and split to into
 
6-well plates, 10
 
6
 
 cells per well. 24 h after transfection, cells were
stimulated in 2 ml of cell culture medium with CpG-ODN (1
 
m
 
M) or Poly I:C (10 
 
m
 
g/ml) for 8 h. Preparation of cell extracts
and luciferase assays were performed according to the manufac-
turer’s instructions (Promega).
 
In Vitro Kinase Assay and Western Blotting.
 
For immune com-
plex kinase assays with hemagglutinin (HA)-tagged kinases,
RAW264.7 cells were transfected with expression vectors for
HA-tagged IKK
 
a
 
 and HA-tagged JNK-1. The cDNA for HA
epitope–tagged human IKK
 
a
 
, a gift from R. Schmid (University
of Ulm, Ulm, Germany), was expressed in pCX (see above), and
HA–JNK-1 was a gift from M. Karin (University of California at
San Diego, La Jolla, CA [18]). 10 (HA-IKK
 
a
 
) and 6 
 
m
 
g (HA-
JNK-1) of these vectors were used together with different
amounts of specific expression vectors as indicated in the figure
legends. The overall amount of plasmid DNA was held constant
at 30 
 
m
 
g per electroporation by adding the appropriate empty ex-
pression vector. After electroporation, cells were washed and split
to 6-well plates, 10
 
6
 
 cells per well. 18 h after transfection, cells
were stimulated in 2 ml of cell culture medium with 2 
 
m
 
M of
phosphothioate-stabilized CpG-ODN or 100 
 
m
 
g of Poly I:C.
Next, immune complex kinase assays were performed using anti-
bodies to the HA tag (clone 12CA5; Boehringer). Kinase assays
and Western blotting were performed as previously described
(13). As substrate for the kinase assays, GST-I
 
k
 
B
 
a
 
(54) was used
for HA-IKK
 
a
 
 and GST-(79)-c-Jun for HA–JNK-1.
 
Results and Discussion
 
TRAF6, originally cloned as a CD40-interacting mole-
cule, is composed of a highly conserved COOH-terminal
TRAF domain and an NH
 
2
 
-terminal effector domain (9,
19). Receptor-independent oligomerization of the NH
 
2
 
terminus is sufficient to induce IKK, whereas JNK and p38
(19), the COOH terminus (TRAF6-C) that seems to serve
as the receptor docking and oligomerization domain of
TRAF6, acts as a dominant negative molecule in CD40-
and TLR/IL-1R–dependent signaling (5, 20, 21). To inves-
tigate, whether TRAF6 is involved in CpG-DNA–induced
signaling, we transiently transfected cells of the macrophage
cell line RAW264.7 with an IL-12 p40 promoter reporter
vector and TRAF6-C. Previously, we had shown that IL-12
p40 is induced in different APCs and macrophage cell lines
by CpG-DNA (13).
As shown in Fig. 1 A, TRAF6-C reduced CpG-DNA–
induced activation of the IL-12 p40 promoter in a concen-
tration-dependent manner. Importantly, dominant-negative
TRAF6 did not affect induction of the IL-12 p40-pro-
moter by double-stranded RNA (poly I:C). Although poly
I:C is a weaker inducer of IL-12 p40 promoter activity
than is CpG-DNA (9- and 32-fold activation, respectively),
it shows that the activity of dominant-negative TRAF6 is
specific for the inhibition of CpG-DNA–induced signaling.
As detailed above, kinases identified as downstream effec-
tors of TRAF6 are the JNKs and IKKs. Although not
shown directly, degradation of I
 
k
 
B
 
a
 
 and phosphorylation
of I
 
k
 
B
 
a
 
 at serine 32/36 after CpG-DNA stimulation (refer-
ence 22 and our unpublished observation) suggested that
IKKs become activated by CpG-DNA. By transient trans-
fection of RAW264.7 cells with an expression vector for 
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HA-tagged IKK
 
a
 
 and subsequent immune complex kinase
assays, we found that CpG-DNA does indeed activate the
IKK complex (Fig. 1 B). Similar results were obtained when
endogenous IKKs (IKK
 
a
 
 and IKK
 
b
 
) were investigated (data
not shown). As shown in Fig. 1 B, activation of IKK
 
a
 
 by
CpG-DNA were reduced when cells were transfected with
increasing amounts of TRAF6-C, but activation of IKK
 
a
 
by Poly I:C was not affected by TRAF6-C (Fig. 1 B).
These results are in accordance with the IL-12 p40 pro-
moter experiments and with earlier observations that this
promoter is activated by transcription factors of the NF-
 
k
 
B
family (23). CpG-DNA has been shown to activate JNK1/2
Figure 1. CpG-DNA signals
via TRAF6. (A) RAW264.7
cells were transiently transfected
with the IL-12 p40-promoter lu-
ciferase reporter and increasing
amounts of an expression vector
for TRAF6-C. Cells were stim-
ulated with 1 mM CpG-ODN
(black bars) or 10 mg/ml Poly I:C
(white bars) for 8 h and lu-
ciferase activity was determined.
Luciferase values are represented
as percentage of activation for
each stimulation relative to cells
transfected in the absence of
TRAF6-C. In this experiment,
CpG-ODN induced 32-fold and
Poly I:C 9-fold activation of the
reporter gene. (B and C)
RAW264.7 cells were tran-
siently transfected with an ex-
pression vector for HA-IKKa
(B) or HA-JNK-1 (C) either to-
gether with a control vector or
with increasing amounts of the expression vector for TRAF6-C as indicated. 24 h after transfection cells were left untreated or stimulated with 2 mM
CpG-ODN for 20 min or 100 mg/ml Poly I:C for 45 (HA-IKKa) or 90 min (HA-JNK-1). C, CpG-ODN; P, Poly I:C. After stimulation, cells were lysed
and kinases were immunoprecipitated with antibodies to the HA tag. In vitro kinase assays were performed with GST-IkBa (B) or GST-cJun(79) (C) as
substrate. Western blot analysis was performed with antibodies to IKKa (B) and JNK-1 (C). The radioactivity incorporated into the substrates was quan-
titated by PhosphorImager analysis (Molecular Dynamics). The obtained values were normalized against the radioactivity obtained in nonstimulated cells
and are presented as fold induction. The results shown are representative of three independent experiments.
Figure 2. CpG-DNA signals
via MyD88. (A) RAW264.7
cells were transiently transfected
with the IL-12 p40-promoter lu-
ciferase reporter and increasing
amounts of an expression vector
for MyD88-C. Cells were stimu-
lated with 1 mM CpG-ODN
(black bars) or 10 mg/ml Poly I:C
(white bars) for 8 h and lu-
ciferase activity was then deter-
mined. Luciferase values are rep-
resented as percentage of
activation for each stimulation
relative to cells transfected in the
absence of MyD88-C. In this ex-
periment, CpG-ODN induced
26-fold and Poly I:C 8-fold acti-
vation of the reporter gene. (B
and C) RAW264.7 cells were
transiently transfected with an
expression vector for HA-IKKa
(B) or HA-JNK-1 (C) either to-
gether with a control vector or
with increasing amounts of the
expression vector for MyD88-C as indicated. 24 h after transfection cells were left untreated or stimulated with 2 mM of CpG-ODN for 20 min or 100
mg/ml of Poly I:C for 45 min (HA-IKKa) or 90 min (HA-JNK-1). C, CpG-ODN; P, Poly I:C. After stimulation, cells were lysed and kinases were im-
munoprecipitated with antibodies to the HA tag. In vitro kinase assays were performed with GST-IkBa (B) or GST-cJun(79) (C) as substrate. Western
blot analysis was performed with antibodies to IKKa (B) and JNK-1 (C). The radioactivity incorporated into the substrates was quantitated by Phosphor-
Imager analysis. The values obtained were normalized against the radioactivity in nonstimulated cells and are presented as fold induction. The data shown
are representative of three independent experiments. 
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and JNK kinase in APCs, leading to phosphorylation of
c-Jun and activation of the transcription factor complex AP-1
(12). Receptor-dependent and receptor-independent oligo-
merization of TRAF6, as well as overexpression of TRAF6,
have also been shown to activate JNK activity (19, 21). On
the other hand, TLR4-induced JNK phosphorylation in
293 cells has been found to be Myd88 dependent, but
TRAF6 independent (24). We therefore addressed whether
CpG-DNA–induced JNK activation would be TRAF6 de-
pendent. Fig. 1 C shows that TRAF6-C suppresses CpG-
DNA–induced JNK-1 activity in a concentration-depen-
dent way. According to the dominant negative activity
of TRAF6-C, overexpression of TRAF6 wild-type in
RAW264.7 macrophages activates JNK-1 (data not shown).
Poly I:C also induced JNK-1; however, this activity was not
affected by TRAF6-C.
Taken together, these data point to TRAF6 as an impor-
tant intermediate of CpG-DNA–induced signal transduc-
tion to the IKK complex and stress kinases JNKs. In con-
trast, Poly I:C activates both the IKK complex and the
JNKs in a TRAF6-independent way. These findings are in
accordance to previous reports that showed that Poly I:C
activates NF-
 
k
 
B in a double-stranded RNA-dependent
protein kinase (PKR)- and IKK
 
b
 
-dependent way (25),
probably through direct binding of regulatory domains of
PKR (26). Therefore, although it induces similar down-
stream effector kinases, Poly I:C seems to activate cells by
pathways that significantly differ from other stimuli of in-
nate immune cells like LPS or CD40.
MyD88, originally isolated as IL-6–induced molecule
during myeloid differentiation (27), was later defined as
essential component of IL-1-, IL-18-, TLR2-, and TLR4-
 
dependent signaling (3, 5, 16, 28). Structurally, it is com-
posed of a COOH-terminal TIR domain, an NH
 
2
 
-terminal
death domain, and an intermediate domain. In func-
tional  terms, its role as adapter molecule first was character-
ized at the IL-1R complex (29). The TIR domain permits
interaction with the receptor chains, then the IRAKs are
recruited to this complex in a transient fashion (7, 8, 29).
Overexpression of the native protein or the NH
 
2
 
 termi-
nus alone is sufficient to induce NF-
 
k
 
B and JNK activa-
tion (29, 30), whereas the COOH terminus can act as a
dominant-negative molecule for TLR/IL-1R dependent
signaling (4, 5, 29). To investigate whether CpG-DNA
signals via MyD88, we used this COOH terminus as a
dominant-negative inhibitor (MyD-C). In analogy to the
experiments with TRAF6 shown above, we transfected
RAW264.7 cells with the IL-12 p40 reporter vector, either
alone or in the presence of MyD-C. Fig. 2 A shows that
increasing amounts of MyD-C inhibit promoter activation,
whereas Poly I:C, used as a specificity control, was not af-
fected. Therefore, CpG-DNA uses the TLR/IL-1R signal-
ing pathway to induce gene expression. Accordingly,
MyD88-C also inhibited CpG-DNA–induced IKK
 
a
 
 acti-
vation (Fig. 2 B) as well as JNK activation in a concentra-
tion-dependent manner (Fig. 2 C). Again, Poly I:C signal-
ing was not affected. Taken together, the results suggest
that CpG-DNA, but not Poly I:C, signals via MyD88 and
TRAF6 to activate the IKK complex and JNKs.
To investigate further whether MyD88 is an essential
component for CpG-DNA–driven cell activation, we per-
formed experiments with cells from MyD88-deficient
mice. Cells from TLR2- and TLR4-deficient mice were
included in these experiments, as TLR2 and TLR4 have
Figure 3. MyD88 is essential for CpG-DNA–induced immune cell activation. (A) Splenocytes (105) of wild-type mice and TLR2-ng, TLR4-, and
MyD88-deficient mice were cultured for 48 h in the presence of CpG-ODN or GpC-ODN (0.1 and 1.0 mM as indicated) or LPS (10 ng/ml). Cells
were pulsed with 1 mCi of [3H]thymidine for the last 8 h and 3H uptake was measured in a b-scintillation counter. Each column represents the mean of
three independent stimulations; error bars are SD. (B) Peritoneal macrophages (5 3 104) of wild-type mice and TLR4- and MyD88-deficient mice were
stimulated with 1 mM CpG-ODN for 24 h and TNF concentrations were determined by ELISA. Each value shown represents the mean and SD of two
independent stimulations. #, not detected. This figure represents the results of one out of two similar, independent experiments. 
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been found to be engaged by PRFs and to signal via
MyD88 (3–5). Although spleen cells of wild-type, TLR2-
deficient, and TLR4-deficient mice proliferated in re-
sponse to CpG-DNA, spleen cells from MyD88-deficient
mice did not (Fig. 3 A). Destruction of the CpG-motif
within CpG-DNA by inversion of the CG dinucleotide to
GC (GpC-ODN) abolished its potential to activate spleen
cells (Fig. 3 A). As expected, LPS induced proliferation in
wild-type and TLR2-deficient cells, but not in TLR4- or
MyD88-deficient cells. Moreover, peritoneal macrophages
from wild-type, TLR2-deficient, and TLR4-deficient mice
produced TNF-
 
a
 
 in response to CpG-DNA but peritoneal
macrophages of MyD88-deficient mice did not (Fig. 3 B).
These data imply that CpG-DNA responses are mediated
through a MyD88-dependent but TLR2- and TLR4-inde-
pendent pathway. Since mice with TLR defects are shown
to be hyporesponsive to different PRFs (2), our data are
consistent with the view that an unknown CpG-DNA re-
ceptor acts upstream of MyD88 and links CpG motif rec-
ognition to the TLR/IL-1R signaling pathway. TRAF6
seems to be a pivot in the activation of immature dendritic
cells, as it is engaged by CD40 ligation via Th cells, by mi-
crobial cell wall components like LPS (11), and by CpG-
DNA. All these results are in line with the concept that it is
the TLR/IL-1R signaling pathway that translates distinct
cell activation signals into a homogeneous biological re-
sponse. MyD88 appears to be the first intracellular media-
tor of signaling through the TLRs and the IL-1R. If the
situation is analogous to CpG-DNA signaling, MyD88
may be a handle to the molecular identification of the pos-
tulated immune receptor for bacterial DNA.
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